CUSIP: 590328100
Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
55,903,603
-
Share change
-
+2,623,052
-
Total reported value
-
$407,356,590
-
Put/Call ratio
-
57%
-
Price per share
-
$7.29
-
Number of holders
-
118
-
Value change
-
+$22,520,801
-
Number of buys
-
60
-
Number of sells
-
51
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM (MACK) as of Q2 2014
As of 30 Jun 2014,
MERRIMACK PHARMACEUTICALS IN - COM (MACK) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,903,603 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, State Street Corp, DEUTSCHE BANK AG\, MILLENNIUM MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., NORTHERN TRUST CORP, and PUTNAM INVESTMENTS LLC.
This page lists
118
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.